[{"orgOrder":0,"company":"Liaoyuan Pharmaceutical","sponsor":"Liaoyuan Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CHINA","productType":"Plant Extract\/Herbal","year":"2017","type":"Inapplicable","leadProduct":"Naoan Dripping","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase IV","graph3":"Liaoyuan Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Liaoyuan Pharmaceutical \/ Liaoyuan Pharmaceutical","highestDevelopmentStatusID":"11","companyTruncated":"Liaoyuan Pharmaceutical \/ Liaoyuan Pharmaceutical"}]

Find Clinical Drug Pipeline Developments & Deals by Liaoyuan Pharmaceutical

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          AIChE Annual Meeting
                          Not Confirmed
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Naoan Dripping is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Migraine Disorders.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          June 05, 2017

                          Lead Product(s) : Naoan Dripping

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase IV

                          Recipient : Dongzhimen Hospital, Beijing

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank